Newsfeeds - Spark Newswire

3 minute read

Allogene Therapeutics Reports Removal Of FDA Clinical Hold Across All AlloCAR T Trials

Today, 1:45 PM

Investigation Confirmed the Chromosomal Abnormality in a Single Patient was Not Observed in Any AlloCAR T Product and Not Related to Allogene Manufacturing Process or TALEN® Gene Editing Clinical Trials Across the

ALLO

1 minute read

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

Today, 1:45 PM

ALLO

1 minute read

RBC Capital Maintains Outperform on Allogene Therapeutics, Lowers Price Target to $35

By Benzinga Newsdesk

Today, 1:45 PM

RBC Capital analyst Luca Issi maintains Allogene Therapeutics (NASDAQ:ALLO) with a Outperform and lowers the price target from $45 to $35.

ALLO

4 minute read

59 Biggest Movers From Yesterday

By Lisa Levin

Today, 1:45 PM

Gainers SeaChange International, Inc. (NASDAQ: SEAC) jumped 128.8% to $1.72 following Bloomberg report suggesting that social video app Triller is in merger talks with Seachange.

ALLO

2 minute read

Movers

12 Health Care Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

Today, 1:45 PM

Gainers

ALLO

8 minute read

Allogene Therapeutics Reports Positive Phase 1 Data From ALPHA Trials In Non-Hodgkin’s Lymphoma At ASH 2021 Meeting

By Benzinga Newsdesk

Today, 1:45 PM

Allogene Therapeutics Reports Positive Phase 1 Data from the ALPHA Trials in Non-Hodgkin's Lymphoma at the 63rd Annual Meeting of the American Society of Hematology ALPHA Trials Demonstrate Potential for AlloCAR

ALLO

3 minute read

The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More

By Shanthi Rexaline

Today, 1:45 PM

Biotech stocks closed out the week ending Dec. 10 with modest losses as investors moved money out of defensives and into risky bets amid the broader market rebound.

ABBV

1 minute read

Cathie Wood’s ARK Invest Posts Fund Purchases For Monday, Nov. 15, 2021: NTLA, TWOU, VCYT, BEAM, MTLS, PRLB, TSP, ACHR, VLD, SPLK, DIS, BFLY, SGFY, ONEM, ALLO, VERV, QSI, HOOD, DKNG, TWLO, TOST, PAG, GRMN, DDD, MKFG

By Benzinga Newsdesk

Today, 1:45 PM

Intellia Therapeutics (NTLA) 2U (TWOU) Veracyte (VCYT) Beam Therapeutics (BEAM) Materialise (MTLS) Proto Labs (PRLB) TuSimple Holdings (TSP) Archer Aviation (ACHR) Velo3d (VLD) Splunk (SPLK) The Walt Disney

ACHR

1 minute read

Cathie Wood’s ARK Invest Posts Fund Purchases For Wednesday, Nov. 3, 2021

By Benzinga Newsdesk

Today, 1:45 PM

Zoom Video (ZM) Exact Sciences (EXAS) Twilio (TWLO) Robinhood (HOOD) UIPath (PATH) DraftKings (DKNG) Intellia Therapeutics (NTLA) Beam Therapeutics (BEAM) Teladoc (TDOC) NIU Technologies

ADPT

32 minute read

Earnings Scheduled For November 4, 2021

By Benzinga Insights

Today, 1:45 PM

Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.

AAOI